In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis


Oyardi Ö., Savage P. B. , Erturan Z., Bozkurt-Guzel C.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol.76, no.2, pp.443-450, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 76 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.1093/jac/dkaa434
  • Journal Name: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, Environment Index, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.443-450
  • Istanbul University Affiliated: Yes

Abstract

Background: Stenotrophomonas maltophilia is a Gram-negative bacterium resistant to several antibiotics and its prevalence in cystic fibrosis (CF) patients is increasing.